These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6800562)

  • 1. Amygdalar noradrenergic and dopaminergic mechanisms in the regulation of hunger and thirst-motivated behavior.
    Lénárd L; Hahn Z
    Brain Res; 1982 Feb; 233(1):115-32. PubMed ID: 6800562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feeding and body weight regulation after 6-OHDA application into the preoptic area.
    Lénárd L; Karádi Z; Jandó G; Yoshimatsu H; Hajnal A; Sándor P; Oomura Y
    Brain Res Bull; 1991; 27(3-4):359-65. PubMed ID: 1959030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS; Smith GP
    Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of noradrenergic innervation compensates for behavioral deficits induced by lesion of dopaminergic terminals in the lateral septum.
    Taghzouti K; Le Moal M; Simon H
    Brain Res; 1991 Jun; 552(1):124-8. PubMed ID: 1717110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body weight changes after neurochemical manipulations of lateral amygdala: noradrenergic and dopaminergic mechanisms.
    Lénárd L; Hahn Z; Karádi Z
    Brain Res; 1982 Oct; 249(1):95-101. PubMed ID: 6814705
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation of noradrenergic and dopaminergic nerves in the rat kidney: evidence against significant dopaminergic innervation.
    McGrath BP; Lim AE; Bode K; Willis GL; Smith GC
    Clin Exp Pharmacol Physiol; 1983; 10(5):543-53. PubMed ID: 6416723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
    Milon H; McRae-Degueurce A
    Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overeating after midbrain 6-hydroxydopamine: prevention by central injection of selective catecholamine reuptake blockers.
    Hernandez L; Hoebel BG
    Brain Res; 1982 Aug; 245(2):333-43. PubMed ID: 6812851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation.
    Herve D; Studler JM; Blanc G; Glowinski J; Tassin JP
    Brain Res; 1986 Sep; 383(1-2):47-53. PubMed ID: 3094831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
    Gálosi R; Petykó Z; Kállai V; Tóth A; Ollmann T; Péczely L; Kovács A; Berta B; Lénárd L
    Behav Brain Res; 2018 May; 344():57-64. PubMed ID: 29454007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional depletion of central nervous system catecholamines: effects on blood pressure and drinking behavior.
    Gordon FJ; Brody MJ; Johnson AK
    Brain Res; 1985 Oct; 345(2):285-97. PubMed ID: 3930004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of different morphine actions by 6-hydroxydopamine and 6-hydroxydopamine plus desmethylimipramine.
    Fuchs V; Coper H
    Psychopharmacology (Berl); 1980 Feb; 67(2):181-8. PubMed ID: 6768093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects after ibotenic acid, 6-OHDA and electrolytic lesions in the central amygdala nucleus of the rat.
    Jellestad FK; Markowska A; Bakke HK; Walther B
    Physiol Behav; 1986; 37(6):855-62. PubMed ID: 3097683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of central noradrenergic system in thyrotropin-releasing hormone-induced behavioral excitement in 6-OHDOPA-treated, infant rats.
    Oki K; Nomura Y; Segawa T
    J Pharmacobiodyn; 1982 Sep; 5(9):716-9. PubMed ID: 6818336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychoneuroendocrine effects of neurotoxic lesions in the septum and striatum of rats.
    Nance DM
    Pharmacol Biochem Behav; 1983 Apr; 18(4):605-9. PubMed ID: 6408652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions.
    Nobrega JN; Coscina DV
    Pharmacol Biochem Behav; 1986 Aug; 25(2):401-9. PubMed ID: 3094039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.